Detalles de la búsqueda
1.
Dose-dense sequential adjuvant chemotherapy in the trastuzumab era: final long-term results of the Hellenic Cooperative Oncology Group Phase III HE10/05 Trial.
Br J Cancer
; 127(4): 695-703, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35610366
2.
Febrile neutropenia (FN) and pegfilgrastim prophylaxis in breast cancer and non-Hodgkin's lymphoma patients receiving high (> 20%) FN-risk chemotherapy: results from a prospective observational study.
Support Care Cancer
; 27(4): 1449-1457, 2019 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-30259136
3.
Dose-dense sequential adjuvant chemotherapy followed, as indicated, by trastuzumab for one year in patients with early breast cancer: first report at 5-year median follow-up of a Hellenic Cooperative Oncology Group randomized phase III trial.
BMC Cancer
; 14: 515, 2014 Jul 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-25026897
4.
Ten-year clinical outcome, toxicity and compliance of dose-dense sequential adjuvant administration of cyclophosphamide & epirubicin followed by docetaxel in patients with early breast cancer: A hellenic cooperative oncology group observational study (HE 10/10) with concurrent investigation of significance of tumor infiltrating lymphocytes.
Breast
; 73: 103668, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38176305
5.
Evaluation of the prognostic role of centromere 17 gain and HER2/topoisomerase II alpha gene status and protein expression in patients with breast cancer treated with anthracycline-containing adjuvant chemotherapy: pooled analysis of two Hellenic Cooperative Oncology Group (HeCOG) phase III trials.
BMC Cancer
; 13: 163, 2013 Mar 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-23537287
6.
The Utility of NGS Analysis in Homologous Recombination Deficiency Tracking.
Diagnostics (Basel)
; 13(18)2023 Sep 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-37761329
7.
Postoperative dose-dense sequential versus concomitant administration of epirubicin and paclitaxel in patients with node-positive breast cancer: 5-year results of the Hellenic Cooperative Oncology Group HE 10/00 phase III Trial.
Breast Cancer Res Treat
; 132(2): 609-19, 2012 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-22187126
8.
Safety and Efficacy of RAD001 (Everolimus) Administered Upon Relapse During or After Adjuvant Treatment in Post-menopausal Women With Hormone Receptor Positive, HER2/neu Negative Locally Advanced or Metastatic Breast Cancer (CRAD001JGR08 "MELPOMENI" study).
Anticancer Res
; 42(2): 1031-1041, 2022 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-35093904
9.
Association between CD8+ Tumor Infiltrating Lymphocytes and the Clinical Outcome of Patients with Operable Breast Cancer Treated with Adjuvant Dose-Dense Chemotherapy-A 10 Year Follow-Up Report of a Hellenic Cooperative Oncology Group Observational Study.
Cancers (Basel)
; 14(22)2022 Nov 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-36428728
10.
A randomized phase III trial of adjuvant chemotherapy with irinotecan, leucovorin and fluorouracil versus leucovorin and fluorouracil for stage II and III colon cancer: a Hellenic Cooperative Oncology Group study.
BMC Med
; 9: 10, 2011 Jan 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-21281463
11.
Evaluation of the prognostic value of CD3, CD8, and FOXP3 mRNA expression in early-stage breast cancer patients treated with anthracycline-based adjuvant chemotherapy.
Cancer Med
; 7(10): 5066-5082, 2018 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-30240146
12.
Associations of angiogenesis-related proteins with specific prognostic factors, breast cancer subtypes and survival outcome in early-stage breast cancer patients. A Hellenic Cooperative Oncology Group (HeCOG) trial.
PLoS One
; 13(7): e0200302, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-30063723
13.
Protein expression patterns of cell cycle regulators in operable breast cancer.
PLoS One
; 12(8): e0180489, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-28797035
14.
The Prognostic Value of the Immunohistochemical Expression of Phosphorylated RB and p16 Proteins in Association with Cyclin D1 and the p53 Pathway in a Large Cohort of Patients with Breast Cancer Treated with Taxane-based Adjuvant Chemotherapy.
Anticancer Res
; 37(6): 2947-2957, 2017 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-28551632
15.
Evaluation of the Prognostic Value of RANK, OPG, and RANKL mRNA Expression in Early Breast Cancer Patients Treated with Anthracycline-Based Adjuvant Chemotherapy.
Transl Oncol
; 10(4): 589-598, 2017 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-28666187
16.
Safety and Tolerability of Anthracycline-Containing Adjuvant Chemotherapy in Elderly High-Risk Breast Cancer Patients.
Clin Breast Cancer
; 16(4): 291-298.e3, 2016 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-26791750
17.
TP53 mutations and protein immunopositivity may predict for poor outcome but also for trastuzumab benefit in patients with early breast cancer treated in the adjuvant setting.
Oncotarget
; 7(22): 32731-53, 2016 May 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-27129168
18.
A novel chromatographic method for Ep-CAM mRNA detection in peripheral blood and bone marrow of patients with metastatic colorectal cancer.
Anticancer Res
; 25(1A): 319-23, 2005.
Artículo
en Inglés
| MEDLINE | ID: mdl-15816554
19.
Large bilateral adrenal metastases in non-small cell lung cancer.
World J Surg Oncol
; 2: 37, 2004 Nov 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-15541184
20.
HLA Class II alleles and the presence of circulating Epstein-Barr virus DNA in Greek patients with nasopharyngeal carcinoma.
Strahlenther Onkol
; 184(6): 325-31, 2008 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-18535809